awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35943654-CA2522DF-9EAB-4077-B108-D2AFE9FA2973
Q35943654-CA2522DF-9EAB-4077-B108-D2AFE9FA2973
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35943654-CA2522DF-9EAB-4077-B108-D2AFE9FA2973
Dose-dense temozolomide: is it still promising?
P2860
Q35943654-CA2522DF-9EAB-4077-B108-D2AFE9FA2973
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35943654-CA2522DF-9EAB-4077-B108-D2AFE9FA2973
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ff21ccdec6673b5d072c2b21cc89cd0d5e2ae96d
P2860
Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma